BioPharmaTrend
Latest Insights
Companies
  • Companies Directory
  • Case Studies
Newsletter
About
  • At a Glance
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
 
 Subscribe 
Sign in
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Business Intelligence
Back to Companies Directory

Allcyte (acquired by Exscientia)

Allcyte logo

Website
https://www.allcyte.com/
Founded
2017

Technologies

AI Companies (Drug Discovery)

Allcyte is a biotech start-up focused on precision medicine and drug development in a patient-centric way using high-content imaging and AI. Allcyte is now be part of Exscientia

health diagnostics

R&D Platform

With our Pharmacoscopy® platform, we generate actionable insights into the functional activity of drugs and drug candidates directly in viable, primary tissue samples of human cancer patients at the single cell level.

Leverage Pharmacoscopy® to enhance the patient relevance of drug discovery and preclinical research across all R&D phases to ultimately increase the chances of success in clinical development.

Learn how Pharmacoscopy® can be used to improve patient response through ex vivo drug screening in primary tumour tissues. Explore big data applications that can drive genetic biomarker and target discovery in oncology.

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
rss  RSS Feed

About


  • What we do
  • Press & Citations
  • Terms of Use
  • Privacy Policy
  • Cookies Policy
  • Disclaimer

Topics


  • News
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures

Explore


  • Premium Insights
  • Business Intelligence
  • Companies
  • Events
  • Authors

Partner


  • Sponsorship
  • Editorial Calendar

© WTMB Research & Media, S.L. (WTMB Group)   2026
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.